Diabetes Marker Linked to COVID-19 Severity in Mice
A sugar that’s less abundant in the blood of people with diabetes binds to SARS-CoV-2’s spike protein and disrupts the virus’s ability to fuse with cells.
ABOVE: Modified from Fig. 4G in Nat Metab, DOI: 10.1038/s42255-022-00567-z, 2022.
Diabetes Marker Linked to COVID-19 Severity in Mice
Diabetes Marker Linked to COVID-19 Severity in Mice
A sugar that’s less abundant in the blood of people with diabetes binds to SARS-CoV-2’s spike protein and disrupts the virus’s ability to fuse with cells.
A sugar that’s less abundant in the blood of people with diabetes binds to SARS-CoV-2’s spike protein and disrupts the virus’s ability to fuse with cells.
ABOVE: Modified from Fig. 4G in Nat Metab, DOI: 10.1038/s42255-022-00567-z, 2022.
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | Nov 2, 2021
Edward Emmott will discuss mass spectrometry approaches to understand proteolysis during viral infection and their use in developing targeted strategies for COVID-19 treatment.
The Scientist spoke with Ohio State University microbiologist Matthew Sullivan about a recent expedition that identified thousands of RNA viruses from water samples and cataloged them into novel phylogenic groups.
A new presidential memorandum requires the Department of Health and Human Services to coordinate a government-wide push to generate a research action plan for the condition.
In addition to causing more frequent natural disasters, global warming can have long-term health effects, which range from heat stress to mosquito-borne disease.
A device smaller than two stacked decks of cards can reliably detect and discriminate between SARS-CoV-2 variants in spit in less than an hour with results that glow.
A study that examined the brains of people before and after SARS-CoV-2 infection found a decrease in brain volume and damage to olfactory areas compared with controls.
Canadian researchers identify a highly mutated variant of the virus in white-tailed deer and link it to a human COVID-19 case in the region—though they emphasize that the infection risk to people is low.
The vaccine’s effectiveness in children ages 5 to 11 rapidly declined over the course of a month, according to new research that looked at the health outcomes of hundreds of thousands of children in New York during the Omicron surge.